A detailed history of Xtx Topco LTD transactions in Novartis Ag stock. As of the latest transaction made, Xtx Topco LTD holds 30,519 shares of NVS stock, worth $3.02 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
30,519
Holding current value
$3.02 Million
% of portfolio
0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $3.24 Million - $3.69 Million
30,519 New
30,519 $3.51 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $416,968 - $458,859
4,519 New
4,519 $456,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $290,904 - $340,226
3,899 New
3,899 $296,000
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $478,416 - $541,182
-5,972 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $475,968 - $526,312
5,972 New
5,972 $522,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.